Philogen Announces R&D Program Update
Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer patients; a new product partnered
Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer patients; a new product partnered
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and
Nguyen Hai CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — As part of its commitment to help producers meet the growing demand for animal protein in
Seattle, July 01, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures
สถานะ All-Star – 14 บริษัทในจีนแผ่นดินใหญ่และ 12 บริษัทในประเทศอื่นๆ ของเอเชียได้อันดับที่หนึ่งอย่างน้อยสี่หมวดหมู่ในภาคส่วนของตน บริษัทต่างๆ ได้รับการพัฒนาขึ้นสู่จุดสูงสุดผ่านโครงการ IR ที่ยอดเยี่ยม, ESG, ความเป็นผู้นำของผู้บริหาร และการรับมือกับโควิด ฮ่องกง, July 01, 2021 (GLOBE NEWSWIRE) — วันนี้ Institutional Investor
In addition, Synchronoss raised $75 million through a private placement of preferred stock Net proceeds used to refinance the company’s capital structure BRIDGEWATER, N.J. ,
Tampa, Florida, June 30, 2021 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology provider Inspirata announced today a multi-year extension of its close partnership with
Welcome to Taiwan Wire Service, your trusted platform for reliable and up-to-date news coverage on Taiwan. We are dedicated to providing comprehensive news articles and features across various topics, including politics, business, technology, culture. More.